Jacquelien D Hoevers

Field safety study of VANGUARD®crLyme: A vaccine for the prevention of Lyme disease in dogs

R. Marconi, Nicole A. Honsberger, V. King, 2020, Vaccine: X.

VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs

D. Schwahn, R. Marconi, Nicole A. Honsberger, 2020, Vaccine: X.

A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.

S. Dunham, S. Mahabir, D. Ramsey, 2016, Veterinary dermatology.

A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.

S. Mahabir, G. Michels, O. Martinon, 2016, Veterinary dermatology.